Author:
García-Basteiro Alberto L.,Ismail Mamudo R.,Carrilho Carla,Ussene Esperança,Castillo Paola,Chitsungo Dércio,Rodríguez Cristina,Lovane Lucília,Vergara Andrea,López-Varela Elisa,Mandomando Inacio,Lorenzoni Cesaltina,Ordi Jaume,Menéndez Clara,Bassat Quique,Martínez Miguel J.
Publisher
Springer Science and Business Media LLC
Reference29 articles.
1. World Health Organization. Global Tuberculosis Report 2014. (WHO/HTM/TB/2014.08, 2014).
2. Uplekar, M. et al. WHO’s new End TB Strategy. Lancet 385, 1799–801 (2015).
3. World Health Organization. High-priority target product profiles for new tuberculosis diagnostics: report of a consensus meeting. (WHO/HTM7TB/2014.18, 2014).
4. World Health Organization. Automated Real-time Nucleic Acid Amplification Technology for Rapid and Simultaneous Detection of Tuberculosis and Rifampicin Resistance: Xpert MTB/RIF System. Policy Statement. (WHO/HTM/TB/2011.4, 2011).
5. Steingart, K. R. et al. Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults. Cochrane Database Syst. Rev. 1, CD009593 (2013).
Cited by
22 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献